Polypharmacy and Quality of Life while Ageing
Bioethical Implications
DOI:
https://doi.org/10.14422/rib.i19.y2022.004Keywords:
polypharmacy, elderly, bioethicsAbstract
The world population is constantly ageing, although life expectancy is increasing because of medical advances. However, longer life expectancy is not directly related to a better quality of life, since there are currently numerous factors, such as polypharmacy, that are accompanied by a morbidity and mortality rate in ageing. Hence, the importance of providing tools that contribute to good practices so that the care of the elderly contributes to healthy ageing.
Downloads
References
Altisent R. (2002). Problemas éticos en la práctica diaria: De la investigación a la prescripción. En Asociación de Bioética Fundamental y Clínica (eds.), La Bioética, diálogo verdadero (pp. 165-172).
Barroso, A. V. y Moral, E. G. (2011). Polimedicación e inadecuación farmacológica: ¿dos caras de la misma moneda? Pharmaceutical Care España, 13(1), 23-23.
Beuscart, J. B., Dalleur, O., Boland, B., Thevelin, S., Knol, W., Cullinan, S., Schneider, C., O’Mahony, D., Rodondi, N. y Spinewine, A. (2017). Development of a core outcome set for medication review in older patients with multimorbidity and polypharmacy: a study protocol. Clinical Interventions in Aging, 12, 1379-1389. https://doi.org/10.2147/CIA.S135481
Deliens, G., Filleul, O., Pepersack, T., Awada, A., Piccart, M., Praet, J-P. y Dal Lago, L. (2016). Drugs prescribed for patients hospitalized in a geriatric oncology unit: Potentially inappropriate medications and impact of a clinical pharmacist. Journal of Geriatric Oncology, 7(6), 463-470. https://doi.org/10.1016/j.jgo.2016.05.001
Esteban Jiménez, Ó., Arroyo Aniés, M. P., Vicens Caldentey, C., González Rubiod, F., Hernández Rodríguez, M. A. y Sempere Manuelf, M. (2018). Deprescribiendo para mejorar la salud de las personas o cuando deprescribir puede ser la mejor medicina. Atención Primaria, 50(2), 70-79. https://doi.org/10.1016/j.aprim.2018.09.001
European Commission. (2016). Joint Report on Health Care and Long-Term Care Systems and Fiscal Sustainability. http://www.medicosypacientes.com/sites/default/files/Informe_6.pdf
Fajardo, P. C., Baena, M. I., Alcaide Andrade, J., Martínez Olmos, J., Faus, M. J. y Martínez-Martínez F. (2005). Adaptación del Método Dáder de seguimiento farmacoterapéutico al nivel asistencial de atención primaria. Pharmacy Practice, 3(3), 158-164.
Fialová, D., Laffon, B., Marinković, V., Tasić, L. Doro, P., Sόos, G., Mota, J., Dogan, S., Brkić, J., Teixeira, J. P., Valdiglesias, V. y Costa, S. (2019). Medication use in older patients and age-blind approach: narrative literature review (insufficient evidence on the efficacy and safety of drugs in older age, frequent use of PIMs and polypharmacy, and underuse of highly beneficial nonpharmacological strategies). European Journal of Clinical Pharmacology, 75, 451-466. https://doi.org/10.1007/s00228-018-2603-5
Guillot, J., Maumus-Robert, S. y Bezin, J. (2020). Polypharmacy: A general review of definitions, descriptions and determinants. Therapies, 75(5), 407-416.
Hernández Ugalde, F., Álvarez Escobar, M. C., Martínez Leyva, G., Junco Sánchez, V. L., Valdés Gasmury, I. y Hidalgo Ruiz, M. (2018). Polifarmacia en el anciano. Retos y soluciones. Revista Médica Electrónica, 40(6), 2053-2070. http://revmedicaelectronica.sld.cu/index.php/rme/article/view/2640
Huizer-Pajkos, A., Kane, A., Howlett, S., Mach, J., Mitchell, S. J., Cabo, R. de, Le Couteur, D. y Hilmer, S. (2016). Adverse Geriatric Outcomes Secondary to Polypharmacy in a Mouse Model: The Influence of Aging. The Journals of Gerontology, 71(5), 571-577. https://doi.org/10.1093/gerona/glv046
Khezrian, M., McNeil, C. J., Murray, A. D. y Myint, P. K. (2020). An overview of prevalence, determinants and health outcomes of polypharmacy. Therapeutic Advances in Drug Safety. https://doi.org/10.1177/2042098620933741
Montiel-Luque, A., Núñez-Montenegro, A. J., Martín-Aurioles, E., Canca-Sánchez, J. C., Toro-Toro M. C. y González-Correa, J. A. (2017). Medication-related factors associated with health-related quality of life in patients older than 65 years with polypharmacy. Plos One, 12(2), e0171320. https://doi.org/10.1371/journal.pone.0171320
Obreli-Neto, P. R., Nobili, A., Oliveira Baldoni, A. de, Molino Guidoni, C., Pereira de Lyra Júnior, D., Pilger, D., Duzanski, J., Tettamanti, M., Cruciol-Souza, J., Penteado Gaeti, W. y Nakamura Cuman, R. (2012). Adverse drug reactions caused by drug-drug interactions in elderly outpatients: a prospective cohort study. European Journal of Clinical Pharmacology, 68(12), 1667-76. https://doi.org/10.1007/s00228-012-1309-3
Pazan, F. y Wehling, M. (2021). Polypharmacy in older adults: a narrative review of definitions, epidemiology and consequences. European Geriatric Medicine, 12, 443-452. https://doi.org/10.1007/s41999-021-00479-3
Riquelme Abreu, I., Álvarez Guerra, S., Ramos Rodríguez, V., Saborido Martín, L. y González Hernández, Z. (2016). Breves consideraciones sobre la bioética en la investigación clínica. Revista Cubana de Farmacia, 50(3). http://www.revfarmacia.sld.cu/index.php/far/article/view/47
Romeo Casabona, C. M. (1999). El derecho y la bioética antes los límites de la vida humana. Centro de Estudios Ramón-Areces.
Sánchez Rodríguez, J. R., Escare-Oviedo, V., Robles-Molina, C., Vergara-Martínez, M. y Jara-Castillo, C. (2019). Polifarmacia en adulto mayor, impacto en su calidad de vida. Revisión de literatura. Revista de salud pública, 21(2), 271-277. https://doi.org/10.15446/rsap.v21n2.76678
Tribunal Europeo de Derechos Humanos. Sentencia núm. 2002/23 de 2 de Julio 2002. http://lawcenter.es/w/file/download/66104
Urzúa, A. y Caqueo-Urízar, A. (2012). Calidad de vida: Una revisión teórica del concepto. Terapia psicológica, 30(1), 61-71. http://dx.doi.org/10.4067/S0718-48082012000100006
Wastesson, J. W., Morin, L., Tan, E. y Johnell, K. (2018). An update on the clinical consequences of polypharmacy in older adults: a narrative review. Expert Opinion on Drug Safety, 17(12), 1185-1196. https://doi.org/10.1080/14740338.2018.1546841
World Health Organization [WHO]. (2021, 4 de octubre). Ageing and health. https://www.who.int/news-room/fact-sheets/detail/ageing-and-health
World Health Organization. (1958). The First ten years of the World Health Organization. World Health Organization. https://apps.who.int/iris/handle/10665/37089
Downloads
Published
How to Cite
Issue
Section
License
The authors of articles published in Revista Iberoamericana de Bioética retain the intellectual property rights over their works and grant the journal their distribution and public communication rights, consenting to their publication under a Creative Commons Attribution-NonCommercial-NoDerivates 4.0 Internacional. Authors are encouraged to publish their work on the Internet (for example, on institutional or personal pages, repositories, etc.) respecting the conditions of this license and quoting appropriately the original source.
